---
figid: PMC6479730__ijms-20-01796-g001
figlink: /pmc/articles/PMC6479730/figure/ijms-20-01796-f001/
number: Figure 1
caption: General representation of the signaling pathways involved in the antagonism
  of both ionotropic and metabotropic glutamate receptors in anti-cancer mediated
  effects. Selective metabotropic glutamate receptor 1 (mGluR1) antagonist JNJ1659685
  elicited its anti-cancer activity, by decreasing cell proliferation, through the
  inhibition of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway,
  and by increasing cell differentiation through the activation of the transcription
  factors small mother against decapentaplegic transcription factor (Smad) 1/5/8.
  LY 341495, an mGluR 2/3 selective antagonist, blocks the activation of both the
  mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK)1/2
  cascade and the Akt/mammalian target of rapamycin protein (mTOR) pathway, resulting
  in arrest of the cell cycle and an increase in apoptosis. Talampanel, a selective
  negative allosteric α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)
  modulator, inhibits the rise of intracellular calcium concentration, and inhibits
  both ERK1/2 and Akt phosphorylation, slowing down the cell proliferation, and increasing
  cellular stiffness through the activation of focal adhesion kinase (FAK) protein.
  The N-methyl-d-aspartate (NMDA) antagonists, MP1 and MP2, two memantine derivative
  compounds, exert their antiproliferative activity by modulating Beclin-1 binding
  protein, which increases the autophagic processes of glioblastoma cell line.
pmcid: PMC6479730
papertitle: 'Glutamate Receptors and Glioblastoma Multiforme: An Old “Route” for New
  Perspectives.'
reftext: Lorenzo Corsi, et al. Int J Mol Sci. 2019 Apr;20(7):1796.
pmc_ranked_result_index: '78555'
pathway_score: 0.9362068
filename: ijms-20-01796-g001.jpg
figtitle: General representation of the signaling pathways involved in the antagonism
  of both ionotropic and metabotropic glutamate receptors in anti-cancer mediated
  effects
year: '2019'
organisms: Homo sapiens
ndex: 16495f30-deb7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6479730__ijms-20-01796-g001.html
  '@type': Dataset
  description: General representation of the signaling pathways involved in the antagonism
    of both ionotropic and metabotropic glutamate receptors in anti-cancer mediated
    effects. Selective metabotropic glutamate receptor 1 (mGluR1) antagonist JNJ1659685
    elicited its anti-cancer activity, by decreasing cell proliferation, through the
    inhibition of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway,
    and by increasing cell differentiation through the activation of the transcription
    factors small mother against decapentaplegic transcription factor (Smad) 1/5/8.
    LY 341495, an mGluR 2/3 selective antagonist, blocks the activation of both the
    mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase
    (ERK)1/2 cascade and the Akt/mammalian target of rapamycin protein (mTOR) pathway,
    resulting in arrest of the cell cycle and an increase in apoptosis. Talampanel,
    a selective negative allosteric α-amino-3-hydroxy-5-methyl-4-isoxazole propionic
    acid (AMPA) modulator, inhibits the rise of intracellular calcium concentration,
    and inhibits both ERK1/2 and Akt phosphorylation, slowing down the cell proliferation,
    and increasing cellular stiffness through the activation of focal adhesion kinase
    (FAK) protein. The N-methyl-d-aspartate (NMDA) antagonists, MP1 and MP2, two memantine
    derivative compounds, exert their antiproliferative activity by modulating Beclin-1
    binding protein, which increases the autophagic processes of glioblastoma cell
    line.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CG
  - PIK3R3
  - SMAD2
  - PIK3CD
  - AKT2
  - MAPK3
  - PTK2
  - GNA11
  - GNA15
  - MAPK1
  - GNA14
  - AKT1
  - MAPK9
  - GNAQ
  - MAPK13
  - MAPK12
  - GRM1
  - MAPK10
  - GRM3
  - MTOR
  - MAPK14
  - GRM2
  - PIK3R4
  - PIK3CB
  - AKT3
  - SMAD1
  - SMAD9
  - SMAD5
  - PIK3CA
  - SMAD3
  - SMAD4
  - MAPK8
  - PIK3R6
  - PIK3R5
  - SMAD6
  - MAPK11
  - SMAD7
  - LY 341495
  - JNJ1659685
  - AMPA
  - NMDA
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Erk1/2,
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA15
  entrez: '2769'
- word: Erk1/2,
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA14
  entrez: '9630'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: mGlu1
  symbol: mGlu1
  source: hgnc_alias_symbol
  hgnc_symbol: GRM1
  entrez: '2911'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: mGlu2/3
  symbol: mGlu3
  source: hgnc_alias_symbol
  hgnc_symbol: GRM3
  entrez: '2913'
- word: m-TOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: mGlu2/3
  symbol: mGlu2
  source: hgnc_alias_symbol
  hgnc_symbol: GRM2
  entrez: '2912'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: Smad1/5/8
  symbol: SMAD8
  source: hgnc_alias_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad1/5/8
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad1/5/8
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
chemicals:
- word: LY 341495
  source: MESH
  identifier: C114624
- word: JNJ1659685
  source: MESH
  identifier: C550935
- word: AMPA
  source: MESH
  identifier: D018350
- word: NMDA
  source: ''
  identifier: ''
diseases: []
---
